Numerous clinical studies have established that angiotensin II receptor blockers are effective as antihypertensive therapy and are well tolerated. Studies demonstrate that adding an angiotensin II ...
Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...
Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...
Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors work to help stop the production ...
LOS ANGELES -- Use of angiotensin receptor blockers (ARBs) was linked to a lower ... associated with the hyperactivation of angiotensin II type 1 receptor and ACE [angiotensin-converting enzyme ...
In terms of branded sales, the angiotensin II receptor blocker class dominates with five of the top ten antihypertensives belonging to this class and generating sales of $10.6 billion in 2006.
A recent study from Columbia University has raised important questions about the medications used to treat high blood ...
The dual-action agent LCZ696 blocks the angiotensin II receptor (via a valsartan moiety ... single-action ACE inhibitors or calcium-channel blockers. Treatment with omapatrilat is associated ...
Dimerix has achieved a key milestone in its ACTION3 phase III trial of lead asset DMX-200 into focal segmental ...
Co. Ltd. has developed new heterocyclic compounds acting as angiotensin AT2 receptor antagonists reported to be useful for the treatment of neuropathy and neuropathic pain.